LIGAND PHARMACEUTICALS INCORPORATED Gain (Loss) on Investments
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Gain (Loss) on Investments of $11.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for the quarter ending 2026-06-30 was $11.75M, a 1151.76% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for the quarter ending 2026-03-31 was $3.87M.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for the quarter ending 2025-12-31 was $22.06M.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for the quarter ending 2025-09-30 was $7.80M, a 223.97% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for fiscal 2025 was $18.43M, a 75.43% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for fiscal 2024 was $75.02M, a 61.81% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for fiscal 2023 was $46.37M, a 62.46% increase from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on investments for fiscal 2022 was $28.54M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 3 month as first filed | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.75M 10-Q · filed 2026-08-07 | $15.62M 10-Q · filed 2026-08-07 | $37.69M derived: sum of 3 quarters · filed 2026-08-07 | $45.48M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $3.87M 10-Q · filed 2026-05-08 | $25.93M derived: sum of 2 quarters · filed 2026-05-08 | $33.73M derived: sum of 3 quarters · filed 2026-05-08 | $34.67M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $22.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $29.86M derived: sum of 2 quarters · filed 2026-02-27 | $30.80M derived: sum of 3 quarters · filed 2026-08-07 | $18.43M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $7.80M 10-Q · filed 2025-11-07 | $8.74M derived: sum of 2 quarters · filed 2026-08-07 | -$3.63M 10-Q · filed 2025-11-07 | -$27.53M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $939.00K 10-Q · filed 2026-08-07 | -$11.43M 10-Q · filed 2026-08-07 | -$35.33M derived: sum of 3 quarters · filed 2026-08-07 | -$32.92M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$12.37M 10-Q · filed 2026-05-08 | -$36.27M derived: sum of 2 quarters · filed 2026-05-08 | -$33.86M derived: sum of 3 quarters · filed 2026-05-08 | -$48.12M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$21.49M derived: sum of 2 quarters · filed 2026-02-27 | -$35.75M derived: sum of 3 quarters · filed 2026-02-27 | $75.02M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $2.41M 10-Q · filed 2025-11-07 | -$11.85M derived: sum of 2 quarters · filed 2025-11-07 | $98.92M 10-Q · filed 2025-11-07 | $114.95M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | -$14.26M 10-Q · filed 2025-08-08 | $96.52M 10-Q · filed 2025-08-08 | $112.54M derived: sum of 3 quarters · filed 2026-02-27 | $99.36M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $110.77M 10-Q · filed 2025-05-09 | $126.80M derived: sum of 2 quarters · filed 2026-02-27 | $113.61M derived: sum of 3 quarters · filed 2026-02-27 | $117.60M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $16.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.84M derived: sum of 2 quarters · filed 2026-02-27 | $6.83M derived: sum of 3 quarters · filed 2026-02-27 | $46.37M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | -$13.18M 10-Q · filed 2024-11-08 | -$9.19M derived: sum of 2 quarters · filed 2024-11-08 | $30.34M 10-Q · filed 2024-11-08 | $74.59M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $3.99M 10-Q · filed 2024-08-07 | $43.52M 10-Q · filed 2024-08-07 | $87.77M derived: sum of 3 quarters · filed 2025-02-28 | $86.85M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $39.53M 10-Q · filed 2024-05-08 | $83.78M derived: sum of 2 quarters · filed 2025-02-28 | $82.86M derived: sum of 3 quarters · filed 2025-02-28 | $80.95M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $44.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $43.33M derived: sum of 2 quarters · filed 2025-02-28 | $41.42M derived: sum of 3 quarters · filed 2025-02-28 | $28.54M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | -$923.00K 10-Q · filed 2023-11-09 | -$2.83M derived: sum of 2 quarters · filed 2023-11-09 | -$15.71M 10-Q · filed 2023-11-09 | -$29.11M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$1.91M 10-Q · filed 2023-08-09 | -$14.79M 10-Q · filed 2023-08-09 | -$28.18M derived: sum of 3 quarters · filed 2024-02-29 | -$26.25M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$12.88M 10-Q · filed 2023-05-08 | -$26.27M derived: sum of 2 quarters · filed 2024-02-29 | -$24.34M derived: sum of 3 quarters · filed 2024-02-29 | -$31.20M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$11.46M derived: sum of 2 quarters · filed 2024-02-29 | -$18.32M derived: sum of 3 quarters · filed 2024-02-29 | -$5.26M 10-K · filed 2024-02-29 | -$4.00M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $1.94M 10-Q · filed 2022-11-08 | -$4.93M derived: sum of 2 quarters · filed 2022-11-08 | $8.13M 10-Q · filed 2022-11-08 | $8.34M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$6.86M 10-Q · filed 2022-08-09 | $6.20M 10-Q · filed 2022-08-09 | $6.41M derived: sum of 3 quarters · filed 2023-02-28 | -$3.46M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $13.06M 10-Q · filed 2022-05-09 | $13.27M derived: sum of 2 quarters · filed 2023-02-28 | $3.41M derived: sum of 3 quarters · filed 2023-02-28 | $26.87M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$9.65M derived: sum of 2 quarters · filed 2023-02-28 | $13.81M derived: sum of 3 quarters · filed 2023-02-28 | -$16.93M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$9.86M 10-Q · filed 2021-11-09 | $13.60M derived: sum of 2 quarters · filed 2021-11-09 | -$17.14M 10-Q · filed 2021-11-09 | -$7.57M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $23.46M 10-Q · filed 2021-08-03 | -$7.28M 10-Q · filed 2021-08-03 | $2.29M derived: sum of 3 quarters · filed 2022-02-28 | -$11.01M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$30.74M 10-Q · filed 2021-05-06 | -$25.46M 10-Q · filed 2020-05-08 | -$21.17M derived: sum of 2 quarters · filed 2022-02-28 | -$34.47M derived: sum of 3 quarters · filed 2022-02-28 | -$49.53M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $9.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$3.72M derived: sum of 2 quarters · filed 2022-02-28 | -$18.79M derived: sum of 3 quarters · filed 2022-02-28 | $1.05M 10-K · filed 2022-02-28 | $2.89M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | -$13.30M 10-Q · filed 2020-11-06 | -$10.52M 10-Q · filed 2019-11-08 | -$28.36M derived: sum of 2 quarters · filed 2020-11-06 | -$8.52M 10-Q · filed 2020-11-06 | -$5.59M 10-Q · filed 2019-11-08 | -$84.89M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | -$15.06M 10-Q · filed 2020-08-07 | -$12.37M 10-Q · filed 2019-08-08 | $4.49M 10-Q · filed 2020-08-07 | $4.93M 10-Q · filed 2019-08-08 | -$71.60M derived: sum of 3 quarters · filed 2021-02-24 | -$9.20M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $17.29M 10-Q · filed 2020-05-08 | -$56.54M derived: sum of 2 quarters · filed 2021-02-24 | $5.86M derived: sum of 3 quarters · filed 2021-02-24 | $45.83M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$73.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$11.43M derived: sum of 2 quarters · filed 2021-02-24 | $28.53M derived: sum of 3 quarters · filed 2021-02-24 | $50.38M 10-K · filed 2021-02-24 | $50.19M 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $62.40M 10-Q · filed 2019-11-08 | $102.36M derived: sum of 2 quarters · filed 2019-11-08 | $124.21M 10-Q · filed 2019-11-08 | $124.76M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $39.96M 10-Q · filed 2019-08-08 | $61.81M 10-Q · filed 2019-08-08 | $62.36M derived: sum of 3 quarters · filed 2020-02-27 | $61.34M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $21.10M 10-Q · filed 2019-05-09 | $22.40M derived: sum of 2 quarters · filed 2020-02-27 | $21.38M derived: sum of 3 quarters · filed 2020-02-27 | $19.98M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $283.00K derived: sum of 2 quarters · filed 2020-02-27 | -$1.12M derived: sum of 3 quarters · filed 2020-02-27 | -$2.05M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$1.02M 10-Q · filed 2018-11-08 | -$2.42M derived: sum of 2 quarters · filed 2018-11-08 | -$3.35M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$1.40M 10-Q · filed 2018-08-08 | -$2.41M 10-Q · filed 2018-08-08 | ||||||
| 2017-03-31 | -$1.08M 10-Q · filed 2018-05-09 |